Your browser doesn't support javascript.
loading
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
Jhaveri, Komal; Wang, Rui; Teplinsky, Eleonora; Chandarlapaty, Sarat; Solit, David; Cadoo, Karen; Speyer, James; D'Andrea, Gabriella; Adams, Sylvia; Patil, Sujata; Haque, Sofia; O'Neill, Tara; Friedman, Kent; Esteva, Francisco J; Hudis, Clifford; Modi, Shanu.
Afiliación
  • Jhaveri K; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Wang R; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Teplinsky E; Valley-Mount Sinai Comprehensive Cancer Care, Paramus, NJ, USA.
  • Chandarlapaty S; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Solit D; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Cadoo K; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Speyer J; Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.
  • D'Andrea G; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Adams S; Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.
  • Patil S; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Haque S; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • O'Neill T; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Friedman K; Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.
  • Esteva FJ; Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.
  • Hudis C; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Modi S; Memorial Sloan-Kettering Cancer Center, New York, NY, USA. modis@mskcc.org.
Breast Cancer Res ; 19(1): 89, 2017 Aug 02.
Article en En | MEDLINE | ID: mdl-28764748

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triazoles / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Triazoles / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos